$WAT News

Waters (WAT) Earnings Expected to Grow: Should You Buy?

Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Waters (WAT) After Recurring Revenue Strength, Is The Valuation Still Compelling?

Q1 Research Tools & Consumables Earnings Review: First Prize Goes to Waters Corporation (NYSE:WAT)

Goldman Sachs Maintains Buy on Waters, Raises Price Target to $425

Waters Corporation Is Getting Awfully Pricey

Waters Corporation's Quarterly Earnings Preview: What You Need to Know

RBC Capital Initiates Coverage of Waters (WAT) with Outperform Recommendation

Morgan Stanley Maintains Equal-Weight on Waters, Raises Price Target to $390

RBC Capital Initiates Coverage On Waters with Outperform Rating, Announces Price Target of $435

Guggenheim Reiterates Buy on Waters, Maintains $440 Price Target

Evercore ISI Group Maintains Outperform on Waters, Raises Price Target to $410

Waters Corp (NYSE:WAT) Shows Strong Growth and Technical Setup

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Bernstein Reinstates Outperform on Waters, Announces $435 Price Target

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings?